Stories & Ideas

Featured blog

Behind the Breakthrough: Q&A with Meena Mallipeddi, AmplifyMD

Meena Mallipeddi is one of the visionary leaders behind AmplifyMD working to e...

Featured blog

The Four Ds of Digital Health

In the dynamic landscape of healthcare's digital transformation, where data ac...

Stories & Ideas

By: F-Prime Capital

Behind the Breakthrough: Q&A with Meena Mallipeddi, AmplifyMD

By: Carl Byers

The Four Ds of Digital Health

By: F-Prime Capital

Behind the Breakthrough: Q&A with Peptone, Kamil Tamiola

Structure Therapeutics

Biologics and peptides have revolutionized healthcare setting the stage for a ne...

By: F-Prime Capital

Behind the Breakthrough: Q&A with Lyn Baranowski, Avalyn Pharma

By: F-Prime Capital

Behind the Breakthrough: Q&A with Stephen Smith, NOCD

By: F-Prime Capital

F-Prime’s Summer Internship Program: Meet our 2023 interns and fellows

By: F-Prime Capital

Behind the Breakthrough: Q&A with Emanuele Ostuni, ARTBIO

Beam Therapeutics

The team developed a DNA base editing technology that enabled more precise edits...

By: Alex Pasteur, Ph.D., Martin Taylor, Ph.D.

ARTBIO: Redefining cancer care through an entirely new class of alpha radioligan...

By: Carl Byers

Why We Invested in Carrot Fertility: A global leader in fertility healthcare and...

CHARM Therapeutics

Predicting the structure and nature of protein-ligand interactions could enable ...

Denali Therapeutics

That needed to change. Through our affiliate FBRI, F-Prime has had a long-standi...

Equip

In 2019, Kristina Saffran and Dr. Erin Parks came to us with a slide deck and a ...

Prime Medicine

Using “search and replace” to address the fundamental causes of genetic disease.

Peptone

Many human proteins are intrinsically disordered and play a critical role in key...

Orchard Therapeutics

But he only had a few pieces in hand. He and his co-founders had some of the mos...

Atalanta

Achieving broad distribution of RNAi therapeutics throughout the CNS has been a ...

AviadoBio

Neurological disease remains the largest cause of disability and second leading ...

K36 Therapeutics

F-Prime has long been interested in precision medicine approaches that tackle th...

Ultragenyx

When he approached us, he was looking for an investor who would understand rare ...

Project Beacon

Boston’s life science community needed efficient, affordable, accessible and equ...

News

ARTBIO

ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials

PR Newswire

Adcentrx Therapeutics Announces China NMPA Grants IND Clearance for ADRX-0706, a Novel Nectin-4 ADC for the Treatment of Advanced Solid Tumors

TIME

TIME100 Health: Bobby Gaspar

Fierce Biotech

CRO GSK and Genomics collab to explore using genetics in clinical trial design

PR Newswire

Rippl acquires AI healthcare startup Kinto to accelerate building nation's most advanced tech-enabled dementia care platform

PR Newswire

New Report Reveals that 9 out of 10 New Mothers Returning to Work Face At Least One Major Challenge That Threatens Career Success